MetLife Investment Management’s Arrowhead Research ARWR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.79M | Sell |
71,062
-69,342
| -49% | -$5.12M | 0.03% | 587 |
|
|
2026
Q1 | $8.8M | Buy |
140,404
+67,364
| +92% | +$4.26M | 0.04% | 399 |
|
|
2025
Q4 | $4.85M | Buy |
73,040
+1,077
| +1% | +$52.8K | 0.02% | 638 |
|
|
2025
Q3 | $2.48M | Hold |
71,963
| – | – | 0.01% | 992 |
|
|
2025
Q2 | $1.14M | Hold |
71,963
| – | – | 0.01% | 1239 |
|
|
2025
Q1 | $917K | Sell |
71,963
-69,048
| -49% | -$1.26M | ﹤0.01% | 1417 |
|
|
2024
Q4 | $2.65M | Buy |
141,011
+9,982
| +8% | +$206K | 0.01% | 903 |
|
|
2024
Q3 | $2.54M | Sell |
131,029
-1,102
| -0.8% | -$26.9K | 0.01% | 901 |
|
|
2024
Q2 | $3.43M | Buy |
132,131
+6,249
| +5% | +$154K | 0.02% | 703 |
|
|
2024
Q1 | $3.6M | Buy |
125,882
+13,059
| +12% | +$418K | 0.02% | 676 |
|
|
2023
Q4 | $3.45M | Sell |
112,823
-948
| -0.8% | -$25.2K | 0.02% | 695 |
|
|
2023
Q3 | $3.06M | Sell |
113,771
-2,641
| -2% | -$80.9K | 0.02% | 699 |
|
|
2023
Q2 | $4.15M | Sell |
116,412
-1,884
| -2% | -$65K | 0.03% | 562 |
|
|
2023
Q1 | $3M | Sell |
118,296
-283
| -0.2% | -$8.9K | 0.02% | 736 |
|
|
2022
Q4 | $4.81M | Sell |
118,579
-1,345
| -1% | -$44.6K | 0.04% | 458 |
|
|
2022
Q3 | $3.96M | Sell |
119,924
-732
| -0.6% | -$29.5K | 0.03% | 528 |
|
|
2022
Q2 | $4.25M | Buy |
120,656
+439
| +0.4% | +$16.5K | 0.03% | 524 |
|
|
2022
Q1 | $5.53M | Buy |
120,217
+34,891
| +41% | +$1.73M | 0.04% | 460 |
|
|
2021
Q4 | $5.66M | Sell |
85,326
-760
| -0.9% | -$52.2K | 0.05% | 346 |
|
|
2021
Q3 | $5.37M | Sell |
86,086
-1,922
| -2% | -$124K | 0.05% | 337 |
|
|
2021
Q2 | $7.29M | Sell |
88,008
-3,393
| -4% | -$253K | 0.06% | 256 |
|
|
2021
Q1 | $6.06M | Sell |
91,401
-4,808
| -5% | -$373K | 0.06% | 314 |
|
|
2020
Q4 | $7.38M | Sell |
96,209
-4,432
| -4% | -$283K | 0.07% | 243 |
|
|
2020
Q3 | $4.33M | Sell |
100,641
-3,981
| -4% | -$172K | 0.05% | 362 |
|
|
2020
Q2 | $4.52M | Buy |
104,622
+4,688
| +5% | +$165K | 0.05% | 334 |
|
|
2020
Q1 | $2.88M | Buy |
99,934
+2,958
| +3% | +$119K | 0.04% | 456 |
|
|
2019
Q4 | $6.15M | Buy |
96,976
+56,016
| +137% | +$2.78M | 0.06% | 272 |
|
|
2019
Q3 | $1.15M | Hold |
40,960
| – | – | 0.01% | 995 |
|
|
2019
Q2 | $1.09M | Sell |
40,960
-81,920
| -67% | -$1.8M | 0.01% | 1067 |
|
|
2019
Q1 | $2.26M | Buy |
122,880
+81,920
| +200% | +$1.35M | 0.01% | 1183 |
|
|
2018
Q4 | $509K | Hold |
40,960
| – | – | 0.01% | 1357 |
|
|
2018
Q3 | $785K | Hold |
40,960
| – | – | 0.01% | 1257 |
|
|
2018
Q2 | $557K | Buy |
+40,960
| New | +$383K | 0.01% | 1347 |
|
Other funds holding ARWR
ACA
FAM
MetLife Investment Management's ARWR Position: Q2 2026 in Review
MetLife Investment Management reduced its Arrowhead Research (ARWR) stake by 49% in Q2 2026, selling an estimated $5.12M and leaving 71,062 shares worth $5.79M. The position accounts for 0.03% of the portfolio, ranked #587.
MetLife Investment Management first reported a position in ARWR in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.8M in Q1 2026. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.
- MetLife Investment Management held 71,062 shares of Arrowhead Research worth $5.79M as of Q2 2026.
- MetLife Investment Management sold 69,342 Arrowhead Research shares in Q2 2026, an estimated $5.12M.
- Arrowhead Research made up 0.03% of MetLife Investment Management's portfolio in Q2 2026, its #587 holding.
- MetLife Investment Management first reported a position in Arrowhead Research in Q2 2018 and has held it in 33 quarters since.
- MetLife Investment Management's Arrowhead Research position peaked at $8.8M in Q1 2026.
- 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.